Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol SpecificInterventions: Drug: carboplatin; Drug: docetaxel; Drug: ifosfamide; Procedure: autologous bone marrow transplantation; Procedure: bone marrow ablation with stem cell support; Procedure: peripheral blood stem cell transplantationSponsors: National Cancer Institute (NCI); Cancer Treatment Centers of AmericaCompleted - verified July 2007
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Chronic Myeloproliferative Neoplasm | Docetaxel | Leukemia | Lymphoma | Research | Stem Cell Therapy | Stem Cells | Taxotere | Transplants